Artwork

Content provided by Norges Bank Investment Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Norges Bank Investment Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Rerun: Lars Fruergaard Jørgensen CEO of Novo Nordisk

38:48
 
Share
 

Manage episode 430466510 series 3330248
Content provided by Norges Bank Investment Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Norges Bank Investment Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Rerun:

“I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug.

The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai Ovenberg. Background research was done by Sigurd Brekke with input from portfolio manager Gemma Game.


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

97 episodes

Artwork
iconShare
 
Manage episode 430466510 series 3330248
Content provided by Norges Bank Investment Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Norges Bank Investment Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Rerun:

“I'm very concerned that European citizens will have lack of access or much lower access to some of the new medicines” says CEO of Novo Nordisk. He also share some interesting perspectives about the importance of purpose and their new weight loss drug.

The production team on this episode were PLAN-B’s Niklas Figenschau Johansen and Nikolai Ovenberg. Background research was done by Sigurd Brekke with input from portfolio manager Gemma Game.


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

97 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide